96
Views
4
CrossRef citations to date
0
Altmetric
Review

Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis

Pages 347-365 | Published online: 03 Mar 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Roy Fleischmann, Imran Iqbal & Richard L Stern. (2006) Tacrolimus in rheumatoid arthritis. Expert Opinion on Pharmacotherapy 7:1, pages 91-98.
Read now

Articles from other publishers (3)

Satoru Mitsuboshi. (2020) Risk of haematological events and preventive effect of folic acid in methotrexate users with chronic kidney disease and rheumatoid arthritis: Analysis of the Japanese Adverse Drug Event Report database. British Journal of Clinical Pharmacology 87:5, pages 2286-2289.
Crossref
Soraya Mezouar, Issa Diarra, Jean Roudier, Benoit Desnues & Jean-Louis Mege. (2019) Tumor Necrosis Factor-Alpha Antagonist Interferes With the Formation of Granulomatous Multinucleated Giant Cells: New Insights Into Mycobacterium tuberculosis Infection. Frontiers in Immunology 10.
Crossref
Xuefeng Yu, Yuefang Huang, Patricia Collin‐Osdoby & Philip Osdoby. (2009) CCR1 Chemokines Promote the Chemotactic Recruitment, RANKL Development, and Motility of Osteoclasts and Are Induced by Inflammatory Cytokines in Osteoblasts. Journal of Bone and Mineral Research 19:12, pages 2065-2077.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.